Methotrexate-Inadequate Response Autoinjector Device Sub Study

Summary

The purpose of this study is to implement a substudy in approximately 120 rheumatoid arthritis (RA) subjects to compare the steady-state serum trough concentration (Cminss), Cmax and area under the curve (AUC) during the dosing interval (TAU) of subcutaneous (SC) Abatacept injection of 125 mg via the autoinjector and via the BD Hypak™ Physiolis prefilled syringe.

Timeline

Start

2013-04

Primary completion

2014-07

Completion

2014-07

Drugs

Indications